Stories, tips, and insights from our Type 1 diabetes community
Dexcom is discontinuing the G6 across the U.S., Canada, the UK, Europe, and Australia as the company shifts to the G7. Users should check pharmacy stock, confirm insurance coverage, and prepare for the transition. The G6 will become increasingly difficult to refill as Dexcom phases out manufacturing and distributors shift inventory to the G7.
A father’s journey running seven marathons on seven continents in seven days is inspiring the global Type 1 Diabetes community. Learn how his mission fuels hope, resilience, and purpose for people living with T1D.
If you live with type 1 diabetes, most “breakthrough” headlines can feel distant from your day-to-day reality of boluses, site changes, and alarms. But a piece of news from this past week is worth pausing on - because it’s not just about better management. It’s about changing when type 1 begins for people at high risk.
Living with T1D means managing so much more than just blood sugar—long-term risks like kidney disease are ever-present for many of us. So when a new study comes along showing solid progress, it’s worth sharing. At ThriveWithType1 we believe in keeping hope alive - and today’s news offers just that.
A $3.2 M NIDDK grant to Scripps Research shines fresh light on how Type 1 Diabetes begins, focusing on rare pancreatic cells and potential prevention strategies.
This week, scientists announced that two people with type 1 diabetes no longer need to take insulin after getting a special transplant of insulin-making cells. They also used a new medicine that helps protect those cells without the strong side effects of older drugs.
If you’re living with type 1 diabetes (T1D), you know the daily rhythm: checking blood sugar, doing insulin doses, watching what you eat. It can feel like you never stop being on guard. But some exciting research published on October 8, 2025, by Scripps Research is giving hope — not just for managing T1D, but for changing the way we think about it.
A first-in-human trial using CRISPR-edited pancreatic cells gives new hope for Type 1 diabetes—insulin production without immune rejection.
This heartfelt article shares a mother's personal journey through her son's Type 1 diabetes diagnosis, highlighting early symptoms to watch for and emphasizing that with the right support, technology, and care, children with the condition can thrive.
From delaying the onset of type 1 diabetes with immunotherapy to restoring insulin production with stem cells and easing life through smart delivery systems, a new era of type 1 diabetes treatment is emerging, but only if access and equity keep pace.
The study develops and validates the Diabetes Strengths and Resilience (DSTAR-Child) scale, a brief measure to assess strengths and resilience in children aged 9 to 13 with type 1 diabetes, showing it is reliable and associated with better emotional well-being and glycemic control.
Morgan’s story at the Children’s Hospital of Philadelphia showcases a young girl's and her family's empowering journey of advocacy, leading to better diabetes support at her school and inspiring confidence and leadership in managing Type 1 Diabetes.
This Johns Hopkins Bloomberg School of Public Health article details significant improvements in glucose control for people with type 1 diabetes over the past 15 years, driven by the widespread adoption of continuous glucose monitoring and insulin delivery technologies.
Young adults with type 1 diabetes (T1D) often struggle with self-management and achieving target glycemic control, and thus, may benefit from additional support during this challenging developmental life stage. They are also some of the highest users of social media (SM), which may have some benefits to young people with T1D.
Developments from two studies highlighting the potential for machine learning leveraging artificial intelligence (AI) technology to improve early-stage identification of type 1 diabetes were presented as late-breaking poster sessions at the 85th Scientific Sessions of the American Diabetes Association® (ADA) in Chicago.
A groundbreaking diabetes treatment at Manning Family Children’s Hospital helped young Ma’Lonniya delay the progression of type 1 diabetes, restoring her energy and happiness while providing hope for her family.
Five inspiring celebrities—including Nick Jonas, Noah Gray, Jean Smart, Sonia Sotomayor, and Este Haim—show that type 1 diabetes can be managed while achieving success in music, sports, entertainment, and public service.
We're thrilled to launch this community platform dedicated to helping people with Type 1 diabetes live their best lives. Discover what exciting features and resources we have planned for you.